NDC 0093-3064

Aspirin and Dipyridamole

Aspirin And Dipyridamole

Aspirin and Dipyridamole is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Aspirin; Dipyridamole.

Product ID0093-3064_069d1ede-b38a-4c75-9773-fba55a0d2294
NDC0093-3064
Product TypeHuman Prescription Drug
Proprietary NameAspirin and Dipyridamole
Generic NameAspirin And Dipyridamole
Dosage FormCapsule, Extended Release
Route of AdministrationORAL
Marketing Start Date2019-06-10
Marketing CategoryANDA / ANDA
Application NumberANDA078804
Labeler NameTeva Pharmaceuticals USA, Inc.
Substance NameASPIRIN; DIPYRIDAMOLE
Active Ingredient Strength25 mg/1; mg/1
Pharm ClassesPlatelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0093-3064-06

60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-3064-06)
Marketing Start Date2019-06-10
Marketing End Date2021-10-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0093-3064-06 [00093306406]

Aspirin and Dipyridamole CAPSULE, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078804
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-06-10

Drug Details

Active Ingredients

IngredientStrength
ASPIRIN25 mg/1

OpenFDA Data

SPL SET ID:1e456280-39d3-4aa7-8322-d30647b5d092
Manufacturer
UNII
Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • UPC Code
  • 0300933064064
  • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722
  • Pharmacological Class

    • Cyclooxygenase Inhibitors [MoA]
    • Decreased Prostaglandin Production [PE]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]
    • Platelet Aggregation Inhibitor [EPC]
    • Decreased Platelet Aggregation [PE]

    NDC Crossover Matching brand name "Aspirin and Dipyridamole" or generic name "Aspirin And Dipyridamole"

    NDCBrand NameGeneric Name
    0093-3040Aspirin and DipyridamoleAspirin and Dipyridamole
    0093-3064Aspirin and DipyridamoleAspirin and Dipyridamole
    0115-1711aspirin and dipyridamoleaspirin and dipyridamole
    0781-2141aspirin and dipyridamoleaspirin and dipyridamole
    16714-964Aspirin and DipyridamoleAspirin and Dipyridamole
    43598-339Aspirin and DipyridamoleAspirin and Dipyridamole
    70436-092aspirin and dipyridamoleaspirin and dipyridamole
    0597-0001Aggrenoxaspirin and dipyridamole
    21695-656Aggrenoxaspirin and dipyridamole
    68151-3971Aggrenoxaspirin and dipyridamole

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.